Stocks and Investing Stocks and Investing
Wed, August 16, 2023
Tue, August 15, 2023

Gregory Renza Reiterated (VIRX) at Buy and Held Target at $7 on, Aug 15th, 2023


Published on 2024-10-28 05:55:33 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Reiterated "Viracta Therapeutics, Inc." (VIRX) at Buy and Held Target at $7 on, Aug 15th, 2023.

Gregory has made no other calls on VIRX in the last 4 months.



There is 1 other peer that has a rating on VIRX. Out of the 1 peers that are also analyzing VIRX, 0 agree with Gregory's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gregory


  • Tony Butler of "EF Hutton" Initiated at Strong Buy and Held Target at $10 on, Monday, July 31st, 2023
Contributing Sources